CN1299744C - One-course and three paste pain relieving paste - Google Patents
One-course and three paste pain relieving paste Download PDFInfo
- Publication number
- CN1299744C CN1299744C CNB2004100241729A CN200410024172A CN1299744C CN 1299744 C CN1299744 C CN 1299744C CN B2004100241729 A CNB2004100241729 A CN B2004100241729A CN 200410024172 A CN200410024172 A CN 200410024172A CN 1299744 C CN1299744 C CN 1299744C
- Authority
- CN
- China
- Prior art keywords
- ointment
- plaster
- paste
- mass ratio
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 229940099259 vaseline Drugs 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 241000124079 Mylabris Species 0.000 claims abstract description 6
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 6
- 241000489492 Arisaema Species 0.000 claims abstract description 5
- 239000002674 ointment Substances 0.000 claims description 56
- 239000003814 drug Substances 0.000 claims description 41
- 239000000463 material Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 241001161070 Calomela Species 0.000 claims description 5
- 241000045019 Huechys sanguinea Species 0.000 claims description 5
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 4
- 210000000941 bile Anatomy 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 3
- 239000011505 plaster Substances 0.000 abstract description 19
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract description 6
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 208000036319 cervical spondylosis Diseases 0.000 abstract description 6
- 208000005801 spondylosis Diseases 0.000 abstract description 6
- 230000002285 radioactive effect Effects 0.000 abstract description 3
- 206010019909 Hernia Diseases 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 235000012907 honey Nutrition 0.000 abstract 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000598860 Garcinia hanburyi Species 0.000 abstract 1
- 241000045021 Huechys Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 239000010075 Qingdai compound Substances 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 229940075397 calomel Drugs 0.000 abstract 1
- 229910052956 cinnabar Inorganic materials 0.000 abstract 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 201000010934 exostosis Diseases 0.000 abstract 1
- 229940117709 gamboge Drugs 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 201000010930 hyperostosis Diseases 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000012467 final product Substances 0.000 description 6
- 244000153234 Hibiscus abelmoschus Species 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 206010005963 Bone formation increased Diseases 0.000 description 3
- 201000002661 Spondylitis Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 2
- 240000001624 Espostoa lanata Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 208000030208 low-grade fever Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010061728 Bone lesion Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000001618 algogenic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003049 pelvic bone Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a one-course three-plaster plaster for treating cure. The plaster is composed of a No. 1 plaster, a No. 2 plaster and a No. 3 plaster, wherein the No. 1 plaster contains huechys, realgar, mylabris and calomel and is compounded into paste by adding honey with the right amount; the raw materials of the No. 2 plaster contain raw arisaema, calcined gypsum powder, borneol, menthol, qingdai and gamboge, and medical powder is stirred evenly into paste with the mixture of vaseline and honey respectively with quality of a half; the No. 3 plaster contains tuber of hyacinth bletilla, dahurian angelica, dragon's blood, frankincense, myrrh, flos caryophyllata, cinnabar and musk, and the medical powder is prepared into paste with the mixture of vaseline and honey respectively with the quality of a half. In treatment, one course of treatment is divided into three times with different plasters. The present invention has good therapeutic effect on, cervical spondylosis, local pain of body surface tissues caused by wind, cold, moisture, factor, fatigue and injury and radioactive pain caused by intervertebral disk hernia, hyperostosis stimulation and oppressive nerve root.
Description
Technical field:
The present invention relates to Chinese medicinal ointment, specifically a kind of seance process is pasted the pain relieving ointment that three obedient different pharmaceuticals are used for the treatment of cureless rheumatic ostalgia disease.
Background technology:
Present domestic medical market external treatment plaster is of a great variety, and is with a long history as the Zhenjiang plaster, spreads so far, and it cures mainly: the traumatic injury wound, and rheumatic arthralgia, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain etc., the primary raw material of its formation is a Chinese medicine.The DONGFANG HUOXUE GAO of pharmaceutical factory, Shandong development in recent years, attending scope is identical with Zhenjiang basically.Also have that Tai Ji is refreshing pastes and bony spur one obedient spirit etc., more than the weak point of these medicines are a kind of plaster, be to fill a prescription and make by one; The clinical curative effect that sticks repeatedly, can only be temporarily to the partial sx of pain or obtain temporary transient alleviation, not obvious for swelling, the numb curative effect of pain that cureless cervical spondylosis, spondylitis, intervertebral disk hernia and the compressing of pelvic bone matter hypertrophy cause.
Summary of the invention:
The purpose of this invention is to provide an a kind of journey three and paste pain relieving ointment, to cervical spondylosis, the local pain that the body surface soft tissue causes because of wind-engaging, cold, wet, heresy and labor, wound, outstanding to the vertebral body intercalated disc, that hyperosteogeny stimulates, pressuring neural root causes radioactive pain has good efficacy.
For achieving the above object, the present invention is made up of No. 1 ointment, No. 2 ointment and No. 3 ointment:
A.1 the material medicine of number ointment becomes smalls by accounting for the Huechys sanguinea De Geer. that mass ratio is 12-15%, the Realgar of 15-18%, the Mylabris of 60-70%, the Calomelas hybrid process of 3-5%, adds Mel again and reconciles into paste;
B.2 the material medicine of number ointment comprises the Gypsum Fibrosum powder (calcined) that accounts for the Rhizoma Arisaematis that mass ratio is 8-12% (Arisaema Cum Bile), 60-70%, the Borneolum Syntheticum of 3-4%, the Mentholum of 3-4%, the blue or green Mount Tai (Indigo Naturalis) of 6-8%, the Resina garciniae of 8-12%, earlier Rhizoma Arisaematis, goa powder are become smalls, porphyrize again sieves blue or green Mount Tai, Gypsum Fibrosum powder (calcined), together mix; get Borneolum Syntheticum, the Mentholum pulverization mixes with preceding medicated powder, the vaseline that respectively accounts for half with quality is mixed well into paste with the mixture of Mel with medicated powder;
C.3 the material medicine of number ointment comprises and accounts for the Pseudobulbus Bletillae (Rhizoma Bletillae) that mass ratio is 18-22%, the Radix Angelicae Dahuricae of 12-15%, the Sanguis Draxonis of 18-22%, the Olibanum of 12-15%, the Myrrha of 12-15%, the Flos Caryophylli of 12-15%, the Cinnabaris of 3.5-4.5%, the Moschus of 0.5-1%, the above Pseudobulbus Bletillae (Rhizoma Bletillae), the Radix Angelicae Dahuricae, Sanguis Draxonis, Olibanum, Myrrha, Flos Caryophylli are processed into smalls, in addition Cinnabaris, Moschus are ground to smalls mixes with adding medicine to, the mixture of getting vaseline that quality respectively accounts for half and Mel is with above-mentioned medicated powder furnishing paste.
Best composition is: the material medicine of No. 1 ointment is that 13% Huechys sanguinea De Geer., 18% Realgar, 65% Mylabris, 4% Calomelas constitute by accounting for mass ratio; The material medicine of No. 2 ointment comprises that accounting for mass ratio is 10% Rhizoma Arisaematis, 66% Gypsum Fibrosum powder (calcined), 3.5% Borneolum Syntheticum, 3.5% Mentholum, 7% blue or green Mount Tai, 10% Resina garciniae formation; The material medicine of No. 3 ointment comprises that accounting for mass ratio is 20.4% the Pseudobulbus Bletillae (Rhizoma Bletillae), 13.6% the Radix Angelicae Dahuricae, 20.4% Sanguis Draxonis, 13.6% Olibanum, 13.6% Myrrha, 13.6% Flos Caryophylli, 4.1% Cinnabaris, 0.7% Moschus.
The using method of No. 1 ointment
Get one in drug of topical application base card according to the agents area size, available SHANGSHI ZHITONG GAO or rheumatalgia relieving plaster substitute, get No. 1 ointment by agents area by about every square decimeter 7 gram evenly the stall with goods spread out on the ground for sale be coated with one deck, drug of topical application base card is bonded at agents area gets final product, No. 1 the ointment application time is 24 hours.
The using method of No. 2 ointment
Get 10 centimeters wide binders, according to folding 4 layers of agents area size, above even stall with goods spread out on the ground for sale was coated in about No. 2 good ointment that will be in harmonious proportion again restrained by every square decimeter 25, the coating area will exceed the size of medication portion, and is good with immobilization with adhesive tape then, avoids friction, slippage is moved, and application time is 24 hours.
The using method of No. 3 ointment
No. 3 ointment is pressed about every square decimeter 18 gram of agents area, and its operational approach is with No. 2 ointment, and application time is 96 hours.
Usage: a course of treatment three medications respectively are ointment No. 1, No. 2, No. 3.
Before pasting No. 1 ointment, earlier agents area is wiped clean with cotton ball soaked in alcohol or Chinese liquor, paste again after waiting to do, stick and took off in 24 hours, the medicated powder scrub of the bubble that skin rose being left over above with dry cotton ball or normal saline then, again blister is wiped out totally together with one of epidermis, or, no longer wiped out the bubble skin to reduce misery directly bubble inner product liquid drainage; Stick ointment then No. 2, treat to remove after 24 hours, change ointment at last No. 3.After No. 3 ointment was thrown off, wound surface was embrocated with gentian voiet and got final product, and can embrocate for several times in 1st, and is uncomfortable as the epidermal stem pain, available erythromycin ointment is coated with one deck, covers one deck pain relieving gauze then and gets final product, and stops a few days, after treating that skin wound recovers former state, can carry out next course of treatment, and the like until recovery from illness.
Normal reaction: after pasting No. 1 ointment and taking off, local visible blister with the equal size of ointment occurs, outflow yellow fluid number milliliter; Yellow mucus continues to ooze out in a large number when pasting No. 2 ointment; Change No. 3 ointment and be the convergence plaster, mucus water reduces, but titillation is arranged, and can not arbitrarily medicine be removed and grabs and scratch.
In therapeutic process, a few peoples have low grade fever and general malaise etc. all to belong to normal reaction.
Agents area: extremities joint, ailing point.Spinal column medication: the lesions position of the vertebral body that applies ointment or plaster, end coccyx from the back hairline, outstanding etc. as cervical spondylosis, spondylitis, hyperosteogeny, lumbar vertebra keyboard, decide according to the tenderness range size of vertebral body pathological changes, a drug area should not be excessive, dosage is too much unsuitable, once only select a position, can take the gradation alternatively administered, can determine scope with reference to X-ray sheet or CT as spondylitis, the medication width can be greater than the spinal column width, about about 2.5 cun.
Prohibit and paste item: the skin of two the moon, oxter, strand ditch and application site has taboos such as ulceration, infection, skin allergy to paste before and after women's head-ornaments portion, the palm of the hand, the sufficient heart, the umbilical part.To eipathia asthenia, patient and the careful usefulness of anemia of pregnant woman child such as serious conscience are arranged.
Points for attention: take a good rest, shun labor, prohibit sexual life during the treatment; Avoid cold and uncooked food, wind sheltering is trembled with fear, the place of applying ointment or plaster prohibits water logging and washes.
The present invention is a medicine for external use, pass through inner disease outer treat, medicine directly is applied to diseased region or ailing point, its useful effect mechanism: 1, medicine is by dermal osmosis and neural reflex, the conduction of meridians body fluid causes the physical and chemical reaction of series, the formation serosity changes, and harmful virulence factor is oozed out in a large number to application site, and this is our seen clinically blister just.2, a journey three is pasted the external application diseased region, the pathological tissues permeability is strengthened, and then foaming draining, the medicament difference of using repeatedly for three times three courses of treatment, water discharge time about three weeks, is cleared up the accumulation of diseased region, periarticular inflammatory exudation and metabolite in succession effectively, for normal circulation outlet has been dredged in the drainage of intralesional algogenic substance, thereby controlled the damage of bone lesion soft tissue effectively, exempted adhesion, contracture to tetanic development.3, in above process, the medicine of applying ointment or plaster is absorbed by body hardly, by a large amount of cases and clinical lab testing report to transudate, in a large amount of leukocyte are arranged, a small amount of erythrocyte, transudate is cultivated and is confirmed that no antibacterial grows, smear inspection bacterium feminine gender, because a large amount of leukocyte increases, transferred the defence and the immunologic function of body, improve resistance simultaneously to disease, we find the phenomenon that the part patient increases with lymphonodi cervicales simultaneously in the therapeutic process of clinical cervical spondylosis, in with a journey three subsides processes, also have the part patient that low grade fever and general malaise etc. are arranged, just proved absolutely this point.
Applying ointment or plaster of No. 1 medicine is that No. 2 medicines are executed to control and laid a good foundation, and makes No. 2 medicines direct performance therapeutical effect rapidly, reaches the blood stasis dispelling toxin expelling, detumescence dampness removing and strengthen the purpose of the function of No. 1 medicine.
No. 3 medicines are strengthened the dissipation of disease on the treatment basis of No. 2 medicines, promoting blood circulation to remove obstruction in the collateral finally reaches and exempts from the numbness analgesic effect, and skin lesion is restrained and the recovery former state, are beneficial to executing of next course of treatment and control.
More than 2, No. 3 medicines all make substrate with Mel, vaseline, in therapeutic process, to note when the wound surface of applying ointment or plaster is changed dressings washing clean wound surface with normal saline.
The present invention is through more than 20 medical institutions units, nearly more than 800 case clinical observations, and total effective rate is more than 95%, the cervical spondylosis effective percentage reached more than 98%, cure rate 80%, late result is consolidated; To the local pain that the body surface soft tissue causes because of wind-engaging, cold, wet, heresy and impairment caused by overstrain, cure rate reaches more than 96%; The radioactive painful fiber crops outstanding to the vertebral body intercalated disc, that hyperosteogeny stimulates, pressuring neural root causes, effective percentage reaches 80%, and cure rate is more than 70%.Its instant effect, the cure rate height, late result does not rebound.
The specific embodiment:
Embodiment
The composition of No. 1 ointment, No. 2 ointment and No. 3 ointment is respectively:
A.1 the material medicine of number ointment is Huechys sanguinea De Geer. 30 gram, Realgar 40 grams, Mylabris 150 grams, Calomelas 10 grams, and hybrid process becomes smalls, adds Mel again and reconciles into paste in right amount and get final product;
B.2 the material medicine of number ointment is Rhizoma Arisaematis 30 grams, Gypsum Fibrosum powder (calcined) 190 grams, Borneolum Syntheticum 10 grams, Mentholum 10 grams, blue or green Mount Tai 20 grams, Resina garciniae 30 grams, earlier Rhizoma Arisaematis, goa powder are become smalls, porphyrize again sieves blue or green Mount Tai, Gypsum Fibrosum powder (calcined), together mix; get Borneolum Syntheticum, Mentholum grinds to the powder and preceding medicated powder mixing for standby use, the time spent gets vaseline that quality respectively accounts for half and with the mixture of Mel medicated powder is mixed well into paste and get final product;
C.3 the material medicine of number ointment is the Pseudobulbus Bletillae (Rhizoma Bletillae) 30 grams, the Radix Angelicae Dahuricae 20 grams, Sanguis Draxonis 30 grams, Olibanum 20 grams, Myrrha 20 grams, Flos Caryophylli 20 grams, Cinnabaris 6 grams, Moschus 1 gram, the above Pseudobulbus Bletillae (Rhizoma Bletillae), the Radix Angelicae Dahuricae, Sanguis Draxonis, Olibanum, Myrrha, Flos Caryophylli are processed into smalls, in addition Cinnabaris, Moschus are also ground to smalls mixes with adding medicine to, the time spent is got vaseline that quality respectively accounts for half and the mixture of Mel gets final product above-mentioned medicated powder furnishing paste.
In No. 2 ointment and No. 3 ointment, be used for medicated powder is reconciled into the vaseline of ointment and the mixture of Mel, the shared ratio of vaseline and Mel can change on a large scale.
Claims (2)
1, an a kind of journey three is pasted pain relieving ointment, and it is made up of No. 1 ointment, No. 2 ointment and No. 3 ointment, it is characterized in that:
A.1 the material medicine of number ointment becomes smalls by accounting for the Huechys sanguinea De Geer. that mass ratio is 12-15%, the Realgar of 15-18%, the Mylabris of 60-70%, the Calomelas hybrid process of 3-5%, adds Mel again and reconciles into paste;
B.2 the material medicine of number ointment is the Arisaema Cum Bile that accounts for mass ratio 8-12%, the Gypsum Fibrosum powder (calcined) of 60-70%, the Borneolum Syntheticum of 3-4%, the Mentholum of 3-4%, the Indigo Naturalis of 6-8%, the Resina garciniae of 8-12%, earlier Arisaema Cum Bile, goa powder are become smalls, porphyrize again sieves Indigo Naturalis, Gypsum Fibrosum powder (calcined), together mix; get Borneolum Syntheticum, the Mentholum pulverization mixes with preceding medicated powder, the vaseline that respectively accounts for half with quality is mixed well into paste with the mixture of Mel with medicated powder;
C.3 the material medicine of number ointment is the Pseudobulbus Bletillae (Rhizoma Bletillae) that accounts for mass ratio 18-22%, the Radix Angelicae Dahuricae of 12-15%, the Sanguis Draxonis of 18-22%, the Olibanum of 12-15%, the Myrrha of 12-15%, the Flos Caryophylli of 12-15%, the Cinnabaris of 3.5-4.5%, the Moschus of 0.5-1%, above Pseudobulbus Bletillae (Rhizoma Bletillae), the Radix Angelicae Dahuricae, Sanguis Draxonis, Olibanum, Myrrha, Flos Caryophylli are processed into smalls, in addition Cinnabaris, Moschus are ground to smalls mixes with adding medicine to, the mixture of getting vaseline that quality respectively accounts for half and Mel is with above-mentioned medicated powder furnishing paste.
2, a journey three according to claim 1 is pasted pain relieving ointments, it is characterized in that: the material medicine of No. 1 ointment is that 13% Huechys sanguinea De Geer., 18% Realgar, 65% Mylabris, 4% Calomelas constitute by accounting for mass ratio; The material medicine of No. 2 ointment is the Arisaema Cum Bile that accounts for mass ratio 10%, 66% Gypsum Fibrosum powder (calcined), 3.5% Borneolum Syntheticum, 3.5% Mentholum, 7% Indigo Naturalis, 10% Resina garciniae; The material medicine of No. 3 ointment is the Pseudobulbus Bletillae (Rhizoma Bletillae) that accounts for mass ratio 20.4%, 13.6% the Radix Angelicae Dahuricae, 20.4% Sanguis Draxonis, 13.6% Olibanum, 13.6% Myrrha, 13.6% Flos Caryophylli, 4.1% Cinnabaris, 0.7% Moschus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100241729A CN1299744C (en) | 2004-05-30 | 2004-05-30 | One-course and three paste pain relieving paste |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100241729A CN1299744C (en) | 2004-05-30 | 2004-05-30 | One-course and three paste pain relieving paste |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1583059A CN1583059A (en) | 2005-02-23 |
| CN1299744C true CN1299744C (en) | 2007-02-14 |
Family
ID=34600806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100241729A Expired - Fee Related CN1299744C (en) | 2004-05-30 | 2004-05-30 | One-course and three paste pain relieving paste |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1299744C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100356930C (en) * | 2005-11-30 | 2007-12-26 | 田向晖 | External-use powder for treating swelling anducler and actue-chronic osteomyelitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081104A (en) * | 1992-07-06 | 1994-01-26 | 杨世泽 | Analgesic plaster for cancer pain and compound method thereof |
| CN1151298A (en) * | 1995-11-30 | 1997-06-11 | 范杰华 | Decomposing and pus drawing-out pellet |
-
2004
- 2004-05-30 CN CNB2004100241729A patent/CN1299744C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081104A (en) * | 1992-07-06 | 1994-01-26 | 杨世泽 | Analgesic plaster for cancer pain and compound method thereof |
| CN1151298A (en) * | 1995-11-30 | 1997-06-11 | 范杰华 | Decomposing and pus drawing-out pellet |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1583059A (en) | 2005-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101214286B (en) | Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases | |
| CN102228586A (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
| CN1055004C (en) | Enternal use adhesive plaster for treatment of rheumatism | |
| CN1143687C (en) | Plaster for treating cervical vertebra hyperplasia | |
| CN1299744C (en) | One-course and three paste pain relieving paste | |
| CN1314441C (en) | Plaster for relaxing the muscles and joints and its prepn process | |
| CN103006992A (en) | External medicinal liquor for relieving swelling and pain and preparation method thereof | |
| CN102218094B (en) | Chinese medicinal preparation for treating traumatic injury and preparation method thereof | |
| CN1883565A (en) | Gel for treating rheumatic arthritis and traumatic injury and method for preparing same | |
| CN101780193A (en) | Special-effect plaster for treating fractures and various non-healing wounds | |
| CN102100867B (en) | Musk rheumatism bone paste | |
| CN101214346B (en) | Chinese medicine emplastrum for treating pain of vertebrae cervicables lumbar intervertebral disc | |
| CN1178686C (en) | Ointment for wound healing | |
| CN1127966C (en) | 'Hehe' ointment and its preparing process | |
| CN101011511A (en) | Externally applied medicament for treating soft tissue injury | |
| CN102225125B (en) | Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof | |
| CN1289120C (en) | Plaster for treating infantile hernia and initial stage lymphoid tuberculosis | |
| CN1233344C (en) | Externally applied piles-treating medicine | |
| CN1319408A (en) | Medicated liquor for treating traumatic injury | |
| CN101703654B (en) | Medicament patch for treating rheumatoid hyperostosis and preparation method thereof | |
| CN1883592A (en) | Gel for treating rheumatism and headache and method for preparing same | |
| CN1294953C (en) | External Chinese materia medica preparation for treating leucoderma | |
| CN1176691C (en) | Medicine for treating rheumatic and rheumatoid disease and its preparation method | |
| CN103385996A (en) | Liquid pain killer and preparation method thereof | |
| CN119174673A (en) | Traditional Chinese medicine medical instrument system for preventing pressure injury and treating 1-3-stage pressure injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070214 Termination date: 20100530 |